Search

Your search keyword '"Maintenance treatment"' showing total 1,266 results

Search Constraints

Start Over You searched for: Descriptor "Maintenance treatment" Remove constraint Descriptor: "Maintenance treatment"
1,266 results on '"Maintenance treatment"'

Search Results

201. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression.

202. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder.

203. Risk of recurrence after a single manic or mixed episode – a systematic review and meta‐analysis.

205. Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

206. Long QTc During Methadone Maintenance: Contributors and Interventions Over 4 Years.

207. Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan.

208. Lenalidomide Maintenance after R-CHOP Therapy in Diffuse Large B-Cell Lymphoma: Can It Be a Standard of Care.

209. Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study.

210. Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta‐analysis

211. Polypharmacy as maintenance treatment in bipolar illness: A systematic review

212. The evolving role of PARP inhibitors in advanced ovarian cancer

213. Pharmacological treatment profiles in the FACE-BD cohort: An unsupervised machine learning study, applied to a nationwide bipolar cohort✰

214. Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis

215. Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis.

216. Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study

218. Malmö Treatment Referral and Intervention Study—High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine/Naloxone Treatment

219. Treatment Progress for EGFR Wild-type Advanced Non-small Cell Lung Cancer

220. Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials

223. Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy

225. Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.

226. Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study.

227. Malmö Treatment referral and intervention study--high 12-Month retention rates in Patients referred from syringe exchange to Methadone or Buprenorphine/naloxone Treatment.

228. Continuous maintenance antipsychotic treatment in schizophrenia.

229. Factors associated with ongoing criminal engagement while in opioid maintenance treatment.

230. Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.

231. Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment.

232. Mortality related to methadone maintenance treatment in Stockholm, Sweden, during 2006-2013.

233. Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study.

234. Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn's Disease.

235. Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis.

236. Pomalidomide and dexamethasone until progression after first salvage therapy in multiple myeloma.

240. Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial.

241. Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia.

242. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial.

243. The Comparison of the Effectiveness of Risperidone and Fluoxetine in Combination with Impulse Control Group Therapy on Improving of Impulsivity, and Relapse in Heroin Crack Addicts under Methadone Maintenance Therapy

245. Tapering antipsychotic medication: Practical considerations

246. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants

247. Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study

248. Adsorptive Granulocyte/Monocyte Apheresis for the Maintenance of Remission in Patients with Ulcerative Colitis: A Prospective Randomized, Double Blind, Sham-Controlled Clinical Trial

250. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial

Catalog

Books, media, physical & digital resources